A Oneindia Venture
Get Updates
Get notified about market trends, financial advice, and investment tips!
Click it and Unblock the Notifications
ITI Pharma and Healthcare Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
76.77% ↑
NAV (₹) on 19 Jun 2026
18.44
1 Day NAV Change
0.78%
Risk Level
Very High Risk
Rating
-
ITI Pharma and Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by ITI Asset Management Limited. Launched on 18 Oct 2021, investors can start with a minimum SIP ... Read more
NAV History
Fund Details
Min. SIP Amount
₹500
Inception Date
18 Oct 2021
Min. Lumpsum Amount
₹ 5,000
Fund Age
4 Yrs
AUM
₹ 237.99 Cr.
Benchmark
NIFTY Healthcare Total Return Index
Expense Ratio
0.68%
Scheme Type
Open Ended
Exit Load
0.5%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 237.99 Cr
Equity
493.03%
Other Assets & Liabilities
6.97%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 71.74% |
| Hospitals & Medical Services | 19.15% |
| Net Receivables/(Payables) | 2.00% |
| Plastics - Plastic & Plastic Products | 1.47% |
| Industrial Gases | 1.30% |
| Finance - Life Insurance | 1.22% |
| Agricultural Products | 1.12% |
| Steel - Tubes/Pipes | 0.81% |
| Medical Equipment & Accessories | 0.68% |
| Finance - Banks - Private Sector | 0.51% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 14.25% | ₹ 33.91 | Pharmaceuticals |
| Divi's Laboratories Limited | 8.43% | ₹ 20.07 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 6.20% | ₹ 14.74 | Hospitals & Medical Services |
| Laurus Labs Limited | 5.06% | ₹ 12.05 | Pharmaceuticals |
| Torrent Pharmaceuticals Limited | 4.90% | ₹ 11.66 | Pharmaceuticals |
| Max Healthcare Institute Limited | 4.90% | ₹ 11.65 | Hospitals & Medical Services |
| Aurobindo Pharma Limited | 4.28% | ₹ 10.19 | Pharmaceuticals |
| Dr. Reddy's Laboratories Limited | 3.98% | ₹ 9.46 | Pharmaceuticals |
| Lupin Limited | 3.53% | ₹ 8.39 | Pharmaceuticals |
| Cipla Limited | 3.42% | ₹ 8.14 | Pharmaceuticals |
| Fortis Healthcare Limited | 3.02% | ₹ 7.19 | Hospitals & Medical Services |
| Neuland Laboratories Limited | 3.00% | ₹ 7.15 | Pharmaceuticals |
| Alkem Laboratories Limited | 2.88% | ₹ 6.85 | Pharmaceuticals |
| Cohance Lifesciences Limited | 2.65% | ₹ 6.31 | Pharmaceuticals |
| Abbott India Limited | 2.03% | ₹ 4.83 | Pharmaceuticals |
| Net Receivables / (Payables) | 2.00% | ₹ 4.75 | Others |
| Mankind Pharma Limited | 1.95% | ₹ 4.64 | Pharmaceuticals |
| Aster DM Healthcare Limited | 1.79% | ₹ 4.25 | Hospitals & Medical Services |
| Sai Life Sciences Limited | 1.63% | ₹ 3.88 | Pharmaceuticals |
| Shaily Engineering Plastics Limited | 1.47% | ₹ 3.50 | Plastics - Plastic & Plastic Products |
| IPCA Laboratories Limited | 1.44% | ₹ 3.43 | Pharmaceuticals |
| Linde India Limited | 1.30% | ₹ 3.09 | Industrial Gases |
| Biocon Limited | 1.26% | ₹ 3 | Pharmaceuticals |
| Piramal Pharma Limited | 1.24% | ₹ 2.94 | Pharmaceuticals |
| Glenmark Pharmaceuticals Limited | 1.23% | ₹ 2.92 | Pharmaceuticals |
| SBI Life Insurance Company Limited | 1.22% | ₹ 2.91 | Finance - Life Insurance |
| Healthcare Global Enterprises Limited | 1.17% | ₹ 2.78 | Hospitals & Medical Services |
| Jubilant Ingrevia Limited | 1.12% | ₹ 2.65 | Agricultural Products |
| Rainbow Childrens Medicare Limited | 1.05% | ₹ 2.51 | Hospitals & Medical Services |
| Shilpa Medicare Limited | 1.04% | ₹ 2.47 | Pharmaceuticals |
| Supriya Lifescience Limited | 1.03% | ₹ 2.46 | Pharmaceuticals |
| Park Medi World Limited | 1.02% | ₹ 2.43 | Hospitals & Medical Services |
| GlaxoSmithKline Pharmaceuticals Limited | 0.86% | ₹ 2.04 | Pharmaceuticals |
| Venus Pipes And Tubes Limited | 0.81% | ₹ 1.94 | Steel - Tubes/Pipes |
| Zydus Lifesciences Limited | 0.76% | ₹ 1.81 | Pharmaceuticals |
| Poly Medicure Limited | 0.68% | ₹ 1.63 | Medical Equipment & Accessories |
| Yes Bank Limited | 0.51% | ₹ 1.22 | Finance - Banks - Private Sector |
| Caplin Point Laboratories Limited | 0.48% | ₹ 1.15 | Pharmaceuticals |
| Syngene International Limited | 0.41% | ₹ 0.99 | Pharmaceuticals |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 2.87% | 8.11% | 11.83% | 20.91% |
| Category returns | 1.68% | 6.17% | 6.53% | 22.14% |
Fund Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. ... Read more
AMC Details
Name
ITI Asset Management Limited
Date of Incorporation
14 May 2018
CEO
Mr. Jatinder Pal Singh
CIO
Mr. Rajesh Bhatia
Type
Pvt.Sector-Indian
Address
ITI House 36,
Dr. R. K. Shirodkar Marg,
Parel Mumbai, Maharashtra, India - 400012
Website
https://www.itiamc.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.47 | 18.71% | 201.11% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.47 | 18.71% | 201.11% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.47 | 18.71% | 201.11% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.45 | 17.51% | 191.18% | 0.00% | ₹9,724 | 1.75% |
Very High
|
Top Funds from ITI Asset Management Limited
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
ITI Small Cap Fund - Direct Plan
Diversified
Direct
|
₹35.59 | 15.57% | 101.71% | 134.64% | ₹3,034 | 0.55% |
Very High
|
|
ITI Small Cap Fund
Diversified
Regular
|
₹31.63 | 13.85% | 92.29% | 114.74% | ₹3,034 | 1.92% |
Very High
|
|
ITI Small Cap Fund - Direct Plan
Diversified
Direct
|
₹33.74 | 13.23% | 91.22% | 122.44% | ₹3,034 | 0.55% |
Very High
|
|
ITI Small Cap Fund - Direct Plan
Diversified
Direct
|
₹33.74 | 13.23% | 91.22% | 122.44% | ₹3,034 | 0.55% |
Very High
|
|
ITI Mid Cap Fund - Direct Plan
Diversified
Direct
|
₹25.24 | 12.33% | 90.73% | 126.43% | ₹1,395 | 0.57% |
Very High
|
|
ITI Small Cap Fund
Diversified
Regular
|
₹29.82 | 11.26% | 81.30% | 102.46% | ₹3,034 | 1.92% |
Very High
|
|
ITI Small Cap Fund
Diversified
Regular
|
₹29.82 | 11.26% | 81.30% | 102.46% | ₹3,034 | 1.92% |
Very High
|
|
ITI Mid Cap Fund
Diversified
Regular
|
₹22.77 | 10.56% | 81.11% | 105.67% | ₹1,395 | 2.09% |
Very High
|
|
ITI Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹18.44 | 8.12% | 76.79% | 0.00% | ₹238 | 0.68% |
Very High
|
|
ITI Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹18.44 | 8.11% | 76.77% | 0.00% | ₹238 | 0.68% |
Very High
|
FAQs
What is the current NAV of ITI Pharma and Healthcare Fund - Direct Plan IDCW?
The current Net Asset Value (NAV) of ITI Pharma and Healthcare Fund - Direct Plan IDCW is ₹18.44 as of 19 Jun 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of ITI Pharma and Healthcare Fund - Direct Plan IDCW?
The Assets Under Management (AUM) of ITI Pharma and Healthcare Fund - Direct Plan IDCW is ₹237.99 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of ITI Pharma and Healthcare Fund - Direct Plan IDCW?
ITI Pharma and Healthcare Fund - Direct Plan IDCW has delivered returns of 8.11% (1 Year), 20.91% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of ITI Pharma and Healthcare Fund - Direct Plan IDCW?
ITI Pharma and Healthcare Fund - Direct Plan IDCW has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for ITI Pharma and Healthcare Fund - Direct Plan IDCW?
The minimum lumpsum investment required for ITI Pharma and Healthcare Fund - Direct Plan IDCW is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹500, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
మ్యూచువల్ ఫండ్ ఇన్వెస్టర్లకు అలర్ట్: మీ డబ్బును కాపాడుకోవడానికి ఈ కొత్త సెబీ రూల్స్ తప్పనిసరి! -
గ్రీన్ ఎనర్జీలో పెట్టుబడికి ఇదే చివరి అవకాశం: మోతీలాల్ ఓస్వాల్ NFO వివరాలు ఇవే! -
AISలో మ్యూచువల్ ఫండ్ వివరాలు మారాయి: ITR ఫైల్ చేసే ముందు ఈ తప్పులు చేయకండి! -
సెబీ కీలక నిర్ణయం: మ్యూచువల్ ఫండ్ ఇన్వెస్టర్ల పెట్టుబడికి ఇక తిరుగులేదా? -
బిగ్ ఫండ్స్ సీక్రెట్ లీక్: దేశంలోని 3 అతిపెద్ద మ్యూచువల్ ఫండ్స్ నమ్ముకున్న ఆ 5 షేర్లు ఇవే! -
స్మాల్క్యాప్ ఇన్వెస్టర్లకు అలర్ట్: ఐసీఐసీఐ ఈటీఎఫ్ ఎన్ఎఫ్ఓ నేడే ముగింపు - మీరు సిద్ధమేనా? -
సింగపూర్ NRI సంచలనం! రూ. కోటిన్నర లాభం వచ్చినా జీరో టాక్స్! కొత్త టాక్స్ రూల్స్లో ఉన్న ట్విస్ట్ ఇదే! -
యాక్సిస్ మ్యూచువల్ ఫండ్ ఇన్వెస్టర్లకు శుభవార్త: ఇకపై ఎగ్జిట్ లోడ్ ఉండదు, పూర్తి వివరాలు ఇవే! -
మార్కెట్ ఒడిదుడుకులు.. అయినా రికార్డు స్థాయిలో SIP పెట్టుబడులు: ఇన్వెస్టర్ల తెలివైన నిర్ణయం! -
ఈక్విటీ ఇన్ ఫ్లోస్ తగ్గుముఖం.. అయినా తగ్గని SIP జోరు: ఇన్వెస్టర్ల తెలివైన నిర్ణయం ఇదే!
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+